Navegar por autor "González Juanatey, Carlos"

Adipokines, biomarkers of endothelial activation, and metabolic syndrome in patients with ankylosing spondylitis

2014- González Juanatey, Carlos; Miranda Filloy, José Alberto

Adiponectin and resistin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-alpha antagonist therapy

2013- González Juanatey, Carlos; Miranda Filloy, José Alberto

Analysis of the influence of the ghrelin receptor rs509035, rs512692 and rs2922126 polymorphisms in the risk of cardiovascular disease in patients with rheumatoid arthritis

2011- González Juanatey, Carlos; Vázquez Rodríguez, Tomás Ramón; Miranda Filloy, José Alberto

Analysis of the Interferon Gamma (rs2430561,+874T/A) Functional Gene Variant in Relation to the Presence of Cardiovascular Events in Rheumatoid Arthritis

2012- González Juanatey, Carlos; Miranda Filloy, José Alberto

Angiographically Guided Complete Revascularization Versus Selective Stress Echocardiography-Guided Revascularization in Patients With ST-Segment-Elevation Myocardial Infarction and Multivessel Disease: The CROSS-AMI Randomized Clinical Trial

2019- Calviño Santos, Ramón; Estevez Loureiro, Rodrigo; PETEIRO VAZQUEZ, JESUS CARLOS; SALGADO FERNANDEZ, JORGE; Rodríguez Vilela, Alejandro; [et al.]

Angioplastia primaria en el Área Norte de Galicia, cambios asistenciales y resultados tras la implantación del programa PROGALIAM

2012- Mesías Prego, José Alejandro; Gutiérrez Cortés, Jose Manuel; Barge Caballero, Eduardo; Vázquez González, Nicolás; Aldama López, Guillermo; [et al.]

Angiopoietin-2 serum levels correlate with severity, early onset and cardiovascular disease in patients with rheumatoid arthritis

2013- González Juanatey, Carlos

Anti-TNF-alpha-adalimumab therapy is associated with persistent improvement of endothelial function without progression of carotid intima-media wall thickness in patients with rheumatoid arthritis refractory to conventional therapy

2012- González Juanatey, Carlos; Vázquez Rodríguez, Tomás Ramón; Miranda Filloy, José Alberto; Testa Fernández, Ana; García Porrúa, Carlos; [et al.]

Anti-TNF-α therapy reduces endothelial cell activation in non-diabetic ankylosing spondylitis patients

2015- González Juanatey, Carlos; Miranda Filloy, José Alberto

Antitumour necrosis factor alpha treatment reduces retinol-binding protein 4 serum levels in non-diabetic ankylosing spondylitis patients

2014- González Juanatey, Carlos; Miranda Filloy, José Alberto

Antitumour necrosis factor-alpha therapy modulates angiopoietin-2 serum levels in non-diabetic ankylosing spondylitis patients

2013- González Juanatey, Carlos; Miranda Filloy, José Alberto

Apelin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-alpha antagonist therapy.

2013- González Juanatey, Carlos; Miranda Filloy, José Alberto

Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial.

2012- González Juanatey, Carlos

Assessment of cardiovascular risk in rheumatoid arthritis: impact of the new EULAR recommendations on the score cardiovascular risk index

2012- González Juanatey, Carlos

Association of acid phosphatase locus 1

2013- González Juanatey, Carlos; Miranda Filloy, José Alberto

Association of acid phosphatase locus 1

2011- González Juanatey, Carlos; Miranda Filloy, José Alberto

Association of the methionine sulfoxide reductase A rs10903323 gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis.

2012- González Juanatey, Carlos; Miranda Filloy, José Alberto

Association study of MIA3 rs17465637 polymorphism with cardiovascular disease in rheumatoid arthritis patients

2012- González Juanatey, Carlos; Miranda Filloy, José Alberto

Asymmetric dimethylarginine serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-alpha antagonist therapy

2013- González Juanatey, Carlos; Miranda Filloy, José Alberto

Atherosclerotic disease in axial spondyloarthritis: increased frequency of carotid plaques

2015- González Juanatey, Carlos

Repositorio digital RUNA

Navegar por autor "González Juanatey, Carlos"

Adipokines, biomarkers of endothelial activation, and metabolic syndrome in patients with ankylosing spondylitis ﻿

Adiponectin and resistin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-alpha antagonist therapy ﻿

Analysis of the influence of the ghrelin receptor rs509035, rs512692 and rs2922126 polymorphisms in the risk of cardiovascular disease in patients with rheumatoid arthritis ﻿

Analysis of the Interferon Gamma (rs2430561,+874T/A) Functional Gene Variant in Relation to the Presence of Cardiovascular Events in Rheumatoid Arthritis ﻿

Angiographically Guided Complete Revascularization Versus Selective Stress Echocardiography-Guided Revascularization in Patients With ST-Segment-Elevation Myocardial Infarction and Multivessel Disease: The CROSS-AMI Randomized Clinical Trial ﻿

Angioplastia primaria en el Área Norte de Galicia, cambios asistenciales y resultados tras la implantación del programa PROGALIAM ﻿

Angiopoietin-2 serum levels correlate with severity, early onset and cardiovascular disease in patients with rheumatoid arthritis ﻿

Anti-TNF-alpha-adalimumab therapy is associated with persistent improvement of endothelial function without progression of carotid intima-media wall thickness in patients with rheumatoid arthritis refractory to conventional therapy ﻿

Anti-TNF-α therapy reduces endothelial cell activation in non-diabetic ankylosing spondylitis patients ﻿

Antitumour necrosis factor alpha treatment reduces retinol-binding protein 4 serum levels in non-diabetic ankylosing spondylitis patients ﻿

Antitumour necrosis factor-alpha therapy modulates angiopoietin-2 serum levels in non-diabetic ankylosing spondylitis patients ﻿

Apelin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-alpha antagonist therapy. ﻿

Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial. ﻿

Assessment of cardiovascular risk in rheumatoid arthritis: impact of the new EULAR recommendations on the score cardiovascular risk index ﻿

Association of acid phosphatase locus 1 ﻿

Association of acid phosphatase locus 1 ﻿

Association of the methionine sulfoxide reductase A rs10903323 gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis. ﻿

Association study of MIA3 rs17465637 polymorphism with cardiovascular disease in rheumatoid arthritis patients ﻿

Asymmetric dimethylarginine serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-alpha antagonist therapy ﻿

Atherosclerotic disease in axial spondyloarthritis: increased frequency of carotid plaques ﻿

Adipokines, biomarkers of endothelial activation, and metabolic syndrome in patients with ankylosing spondylitis

Adiponectin and resistin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-alpha antagonist therapy

Analysis of the influence of the ghrelin receptor rs509035, rs512692 and rs2922126 polymorphisms in the risk of cardiovascular disease in patients with rheumatoid arthritis

Analysis of the Interferon Gamma (rs2430561,+874T/A) Functional Gene Variant in Relation to the Presence of Cardiovascular Events in Rheumatoid Arthritis

Angiographically Guided Complete Revascularization Versus Selective Stress Echocardiography-Guided Revascularization in Patients With ST-Segment-Elevation Myocardial Infarction and Multivessel Disease: The CROSS-AMI Randomized Clinical Trial

Angioplastia primaria en el Área Norte de Galicia, cambios asistenciales y resultados tras la implantación del programa PROGALIAM

Angiopoietin-2 serum levels correlate with severity, early onset and cardiovascular disease in patients with rheumatoid arthritis

Anti-TNF-alpha-adalimumab therapy is associated with persistent improvement of endothelial function without progression of carotid intima-media wall thickness in patients with rheumatoid arthritis refractory to conventional therapy

Anti-TNF-α therapy reduces endothelial cell activation in non-diabetic ankylosing spondylitis patients

Antitumour necrosis factor alpha treatment reduces retinol-binding protein 4 serum levels in non-diabetic ankylosing spondylitis patients

Antitumour necrosis factor-alpha therapy modulates angiopoietin-2 serum levels in non-diabetic ankylosing spondylitis patients

Apelin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-alpha antagonist therapy.

Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial.

Assessment of cardiovascular risk in rheumatoid arthritis: impact of the new EULAR recommendations on the score cardiovascular risk index

Association of acid phosphatase locus 1

Association of acid phosphatase locus 1

Association of the methionine sulfoxide reductase A rs10903323 gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis.

Association study of MIA3 rs17465637 polymorphism with cardiovascular disease in rheumatoid arthritis patients

Asymmetric dimethylarginine serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-alpha antagonist therapy

Atherosclerotic disease in axial spondyloarthritis: increased frequency of carotid plaques